Search results
Results From The WOW.Com Content Network
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Moderna wasn’t one of them. The 10 stocks that made the cut ...
Shares of vaccine maker Moderna (MRNA), a $26.5 billion company that lost half a billion dollars over the past year on sales of barely $50 million, are up more than four times from the $18-and ...
Moderna held its annual R&D day this week. Moderna's (NASDAQ: MRNA) struggles may last a little longer than expected. The biotech company had seen both sales and its stock price plummet as demand ...
Moderna (MRNA) closed at $122.15 in the latest trading session, marking a -0.07% move from the prior day. Moderna (MRNA) Stock Sinks As Market Gains: What You Should Know Skip to main content
The Oslo Stock Exchange (Norwegian: Oslo Børs) serves as the main market for trading in the shares of Norwegian companies. It opens at 9:00am and closes 4:30pm local time ( CET ). In addition to a wide range of domestic companies, the OSE attracts a lot of international companies within petroleum , shipping and other related areas.
For premium support please call: 800-290-4726 more ways to reach us
For premium support please call: 800-290-4726 more ways to reach us
BioNTech was founded in 2008 based on research by Uğur Şahin, Özlem Türeci, [8] and Christoph Huber, [9] with a seed investment of €180 million [10] from MIG Capital, a Munich-based venture capital firm, the family office of Andreas and Thomas Strüngmann, and the present chairman of the supervisory board, Helmut Jeggle.